A Feasibility Trial of Concurrent Radiation, Temozolomide, and Bevacizumab Followed by Temozolomide and Bevacizumab for Resectable and Unresectable Glioblastoma Multiforme of the Brain

被引：1
|
作者：
Liebross, R. H. [1 ,2 ]
Birhiray, R. [2 ,3 ]
Schultz, S. [2 ,4 ]
Payner, T. [2 ,5 ]
Gupta, N. [2 ,4 ]
Young, R. [2 ,5 ]
Cohen-Gadol, A. [2 ,5 ]
Kuzma, B. [2 ,6 ]
Givens, S. [1 ,2 ]
Leagre, C. [1 ,2 ]
机构：
[1] Canc Care Grp LLC, Indianapolis, IN USA
[2] St Vincent Hosp, Indianapolis, IN USA
[3] Hematol Oncol Indiana, Indianapolis, IN USA
[4] Amer Hlth Network, Indianapolis, IN USA
[5] Goodman Campbell Brain & Spine, Indianapolis, IN USA
[6] NW Radiol, Indianapolis, IN USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.474
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S275 / S275
页数：1
相关论文
共 50 条
  • [1] A Feasibility Trial of Concurrent Radiation, Temozolomide, and Bevacizumab followed by Temozolomide and Bevacizumab for Resectable and Unresectable Glioblastoma Multiforme of the Brain
    Liebross, R. H.
    Leagre, C.
    Schultz, S.
    Payner, T.
    Sartorius, C.
    Young, R.
    Cohen-Gadol, A.
    Kuzma, B.
    Givens, S.
    Birhiray, R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S125 - S125
  • [2] BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND IRINOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Vredenburgh, James
    Desjardins, Annick
    Reardon, David
    Rich, Jeremy
    Kirkpatrick, John
    Gururangan, Sridharan
    Bailey, Leighann
    Friedman, Allan
    Bigner, Darell
    Friedman, Henry
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 836 - 837
  • [3] FEASIBILITY OF COMBINED TREATMENT WITH BEVACIZUMAB, RADIOTHERAPY, AND TEMOZOLOMIDE IN RESECTABLE AND UNRESECTABLE NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    van Linde, Myra E.
    Verhoeff, Joost J. C.
    Stalpers, Lukas J. A.
    Reijneveld, Jaap C.
    Richel, Dirk J.
    Van Furth, Wouter Ralph
    [J]. NEURO-ONCOLOGY, 2009, 11 (05) : 628 - 628
  • [4] THE ADDITION OF BEVACIZUMAB TO TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE, AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Vredenburgh, James J.
    Desjardins, Annick
    Reardon, David A.
    Peters, Katherine B.
    Kirkpatrick, John P.
    Herndon, James E., II
    Coan, April D.
    Bailey, Leighann
    Janney, Dorothea
    Lu, Cynthia
    Friedman, Henry S.
    [J]. NEURO-ONCOLOGY, 2011, 13 : 89 - 90
  • [5] Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Peters, K.
    Kirkpatrick, J.
    Coan, A. D.
    Bailey, L.
    Janney, D.
    Lu, C.
    Friedman, H. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Safety and efficacy of the addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma multiforme
    Vredenburgh, James J.
    Desjardins, Annick
    Peters, Katherine B.
    Reardon, David A.
    Herndon, James Emmett
    Coan, April D.
    Kirkpatrick, John
    Bailey, Leighann
    Threatt, Stevie
    Sampson, John Howard
    Friedman, Allan H.
    Friedman, Henry S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] The addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly diagnosed glioblastoma multiforme (GBM).
    Friedman, Henry S.
    Desjardins, Annick
    Peters, Katherine B.
    Reardon, David A.
    Kirkpatrick, John
    Herndon, James Emmett
    Coan, April D.
    Bailey, Leighann
    Sampson, John Howard
    Friedman, Allan H.
    Vredenburgh, James J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] PHASE II TRIAL OF UPFRONT BEVACIZUMAB WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Ranjan, Tulika
    Desjardins, Annick
    Peters, Katherine B.
    Alderson, Lloyd
    Kirkpatrick, John
    Herndon, James, II
    Bailey, Leighann
    Sampson, John
    Friedman, Allan H.
    Friedman, Henry
    Vredenburgh, James J.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 79 - 79
  • [9] Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
    Shields, Lisa B. E.
    Kadner, Robert
    Vitaz, Todd W.
    Spalding, Aaron C.
    [J]. RADIATION ONCOLOGY, 2013, 8
  • [10] Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
    Lisa BE Shields
    Robert Kadner
    Todd W Vitaz
    Aaron C Spalding
    [J]. Radiation Oncology, 8
12345